These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 31574818)
1. Renal and pulmonary thrombotic microangiopathy triggered by proteasome-inhibitor therapy in patient with smoldering myeloma: A renal biopsy and autopsy case report. Cassol CA; Williams MPA; Caza TN; Rodriguez S Medicine (Baltimore); 2019 Sep; 98(39):e17148. PubMed ID: 31574818 [TBL] [Abstract][Full Text] [Related]
2. Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma. Hobeika L; Self SE; Velez JC BMC Nephrol; 2014 Sep; 15():156. PubMed ID: 25267524 [TBL] [Abstract][Full Text] [Related]
3. Thrombotic microangiopathy associated with monoclonal gammopathy. Ravindran A; Go RS; Fervenza FC; Sethi S Kidney Int; 2017 Mar; 91(3):691-698. PubMed ID: 27998645 [TBL] [Abstract][Full Text] [Related]
4. Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition. Catanese L; Link K; Rupprecht H BMC Nephrol; 2023 Jun; 24(1):179. PubMed ID: 37337151 [TBL] [Abstract][Full Text] [Related]
5. Influenza-induced thrombotic microangiopathy in a patient with cancer on proteasome inhibitor: a diagnostic dilemma. Hamad CD; Hoelscher ZC; Tchakarov A; Kala J CEN Case Rep; 2022 Aug; 11(3):321-327. PubMed ID: 34997535 [TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibitor associated thrombotic microangiopathy. Yui JC; Van Keer J; Weiss BM; Waxman AJ; Palmer MB; D'Agati VD; Kastritis E; Dimopoulos MA; Vij R; Bansal D; Dingli D; Nasr SH; Leung N Am J Hematol; 2016 Sep; 91(9):E348-52. PubMed ID: 27286661 [TBL] [Abstract][Full Text] [Related]
7. Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the Literature. Monteith BE; Venner CP; Reece DE; Kew AK; Lalancette M; Garland JS; Shepherd LE; Pater JL; Hay AE Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e791-e800. PubMed ID: 32807717 [TBL] [Abstract][Full Text] [Related]
8. Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report. Nishikubo M; Shimomura Y; Hiramoto N; Sawamura N; Yamaguchi T; Hara S; Ishikawa T BMC Nephrol; 2021 May; 22(1):175. PubMed ID: 33980166 [TBL] [Abstract][Full Text] [Related]
10. Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma. Rassner M; Baur R; Wäsch R; Schiffer M; Schneider J; Mackensen A; Engelhardt M BMC Nephrol; 2021 Jan; 22(1):32. PubMed ID: 33461512 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature. Usui J; Glezerman IG; Salvatore SP; Chandran CB; Flombaum CD; Seshan SV Hum Pathol; 2014 Sep; 45(9):1918-27. PubMed ID: 25087655 [TBL] [Abstract][Full Text] [Related]
12. Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study. Camilleri M; Cuadrado M; Phillips E; Wilson W; Jenner R; Pang G; Kamora S; Streetly M; Popat R; Bygrave C; Owen R; Cavenagh J; Chapman M; Sive J; Eccersley L; Sheaff M; Benjamin R; Ramasamy K; Cook G; Virchis A; Chavda SJ; Clifton-Hadley L; Scully MA; Yong K Br J Haematol; 2021 May; 193(4):750-760. PubMed ID: 33650100 [TBL] [Abstract][Full Text] [Related]
13. Two cases of idiopathic steroid-resistant nephrotic syndrome complicated with thrombotic microangiopathy. Nishi K; Sato M; Ogura M; Okutsu M; Ishikura K; Kamei K BMC Nephrol; 2020 Aug; 21(1):323. PubMed ID: 32746791 [TBL] [Abstract][Full Text] [Related]
14. Association of thrombotic microangiopathy with interferon therapy for hepatitis B: a case report. Wei S; Mei W; Wang Y J Med Case Rep; 2024 Jul; 18(1):321. PubMed ID: 38965631 [TBL] [Abstract][Full Text] [Related]
15. Kidney Biopsy Proven Thrombotic Microangiopathy Induced by Methamphetamine. Nagaoka K; Katagiri D; Matsunami M; Chinen M; Seki K; Fukuda J; Ohara M; Suzuki T Intern Med; 2024 Jun; 63(11):1603-1608. PubMed ID: 37866922 [TBL] [Abstract][Full Text] [Related]
16. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients. Page EE; Little DJ; Vesely SK; George JN Am J Kidney Dis; 2017 Nov; 70(5):686-695. PubMed ID: 28780041 [TBL] [Abstract][Full Text] [Related]
17. Thrombotic microangiopathy induced by long-term interferon-β therapy for multiple sclerosis: a case report. Broughton A; Cosyns JP; Jadoul M Clin Nephrol; 2011 Nov; 76(5):396-400. PubMed ID: 22000560 [TBL] [Abstract][Full Text] [Related]